Revolution Medicines Market Sentiment

Revolution Medicines Inc

RVMDNASDAQ

$184.81

-1.41-0.76%

Ult. Agg.: Oct 28, 10:01 AM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Rapporto azionario

Utili: I risultati di Q3 2026 tra 7 giorni da adesso in mer nov 4th, dopo la chiusura del mercato

Conference call: Conference call programmata per tra 7 giorni alle 4:30 PM

Clicca per vedere il webcast

Revolution Medicines Market Sentiment - Benzinga

Revolution Medicines Market Sentiment

Market sentiment signals for Revolution Medicines (RVMD): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 5.9% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

30 analysts

Options Flow (P/C)

—

Avg Consensus PT

$202

+9.3%

Highest Price Target

$320

+73.2%

Evercore ISI Group

Lowest Price Target

$67

-63.7%

Wells Fargo

Short Interest

5.9%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	TD Cowen	Tyler Van Buren—	+35.3%	$250	Maintained	Buy
Oct 19, 2026	Truist Securities	Gregory Renza—	+30.4%	$240 → $241	Maintained	Buy
Oct 16, 2026	William Blair	Alethia Young—	—	—	Initiate	Outperform
Oct 15, 2026	Needham	Ami Fadia—	+48.8%	$275 → $275	Maintained	Buy
Oct 14, 2026	RBC Capital	Leonid Timashev—	+40.7%	$259 → $260	Maintained	Outperform
Oct 8, 2026	RBC Capital	Leonid Timashev—	+40.1%	$251 → $259	Maintained	Outperform
Oct 7, 2026	Truist Securities	Gregory Renza—	+29.9%	$239 → $240	Maintained	Buy
Sep 28, 2026	Brookline Capital	Leah Rush—	+72.1%	$318	Initiate	Buy
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	+44.5%	$267	Reinstates	Buy
Sep 21, 2026	B of A Securities	Alec Stranahan—	+43.4%	$225 → $265	Maintained	Buy
Sep 10, 2026	Morgan Stanley	Sean Laaman—	+38.0%	$255	Initiate	Overweight
Sep 9, 2026	Stifel	Laura Prendergast—	+24.5%	$215 → $230	Maintained	Buy
Aug 31, 2026	Needham	Ami Fadia—	+48.8%	$240 → $275	Maintained	Buy
Aug 28, 2026	UBS	Michael Yee—	+43.4%	$220 → $265	Maintained	Buy
Aug 28, 2026	Guggenheim	Michael Schmitz—	+48.8%	$240 → $275	Maintained	Buy
Aug 27, 2026	Oppenheimer	Jay Olson—	+40.7%	$230 → $260	Maintained	Outperform
Aug 27, 2026	RBC Capital	Leonid Timashev—	+35.8%	$203 → $251	Maintained	Outperform
Aug 27, 2026	Wedbush	Robert Driscoll—	+21.7%	$201 → $225	Maintained	Outperform
Aug 27, 2026	Truist Securities	Gregory Renza—	+29.3%	$231 → $239	Maintained	Buy
Aug 27, 2026	Evercore ISI Group	Cory Kasimov—	+73.2%	$230 → $320	Maintained	Outperform
Aug 27, 2026	HC Wainwright & Co.	Robert Burns—	+51.5%	$195 → $280	Maintained	Buy
Aug 21, 2026	Bernstein	Jeffrey Walch—	-3.1%	$151 → $179	Maintained	Market Perform
Aug 11, 2026	Truist Securities	Gregory Renza—	+25.0%	$210 → $231	Maintained	Buy
Aug 6, 2026	RBC Capital	Leonid Timashev—	+9.8%	$182 → $203	Maintained	Outperform
Aug 6, 2026	Wedbush	Robert Driscoll—	+8.8%	$192 → $201	Maintained	Outperform